Home › Funds › T. Rowe Price › T. Rowe Price Tax-Efficient Equity Fund
Fund family: T. Rowe Price · Filed by T. Rowe Price Tax-Efficient Funds, Inc. (CIK 1038490) · SEC series S000002160
Share classes and tickers: PREFX (C000005556), TEEFX (C000193192)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 3,576 with, 132 against, 0 abstentions (not counted as with management); 5 items carried no recommendation. Shareholder proposals: 25 FOR, 109 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as T. Rowe Price’s manager page (244,024 ballot items across 112 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | T. Rowe Price | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 86.9% | 3,464 | 93.7% | 208,710 |
| Backed environmental and social shareholder proposals at US companies | 0.0% | 61 | 2.6% | 3,333 |
Each ballot item this fund voted is set against the votes of the other T. Rowe Price funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most T. Rowe Price funds on 239 items (6.6% of the 3,609 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most T. Rowe Price funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Microsoft Corporation | 2025-12-05 | Advisory Vote to Approve Named Executive Officer Compensation ("say-on-pay vote") | Against | FOR — 49 of 49 T. Rowe Price funds | Against | Passed (calculated), 91.9% support |
| Apple Inc. | 2026-02-24 | Advisory vote to approve executive compensation | Against | FOR — 42 of 42 T. Rowe Price funds | Against | Approved, 91.4% support |
| NVIDIA Corporation | 2026-06-24 | Advisory approval of our executive compensation. | Against | FOR — 44 of 44 T. Rowe Price funds | Against | Approved, 93.6% support |
| Meta Platforms, Inc. | 2026-05-27 | Shareholder A shareholder proposal regarding annual vote regarding executive pay. | Against | FOR — 43 of 43 T. Rowe Price funds | For | Not approved, 27.1% support |
| Meta Platforms, Inc. | 2026-05-27 | Election of Directors: Dana White | Withhold | FOR — 42 of 42 T. Rowe Price funds | Against | Elected, 91.4% support |
| Eli Lilly and Company | 2026-05-04 | Approval, on an advisory basis, of the compensation paid to the company's named executive officers. | Against | FOR — 45 of 45 T. Rowe Price funds | Against | Approved, 96.0% support |
| Advanced Micro Devices, Inc. | 2026-05-13 | Approve on a non-binding, advisory basis the compensation of the named executive officers, as disclosed in the proxy statement pursuant to the compensation disclosure rules of the U.S. Securities and Exchange Commission. | Against | FOR — 43 of 43 T. Rowe Price funds | Against | Approved, 92.6% support |
| UnitedHealth Group Incorporated | 2026-06-01 | Advisory approval of the Company's executive compensation. | Against | FOR — 45 of 45 T. Rowe Price funds | Against | Approved, 82.6% support |
| GE Aerospace | 2026-05-05 | Advisory Approval of Our Named Executives' Compensation | Against | FOR — 42 of 42 T. Rowe Price funds | Against | — |
| Visa Inc. | 2026-01-27 | To approve, on an advisory basis, the compensation paid to our named executive officers. | Against | FOR — 39 of 39 T. Rowe Price funds | Against | Approved, 93.5% support |
| Mastercard Incorporated | 2026-06-16 | Advisory approval of Mastercard's executive compensation | Against | FOR — 40 of 40 T. Rowe Price funds | Against | Approved, 94.9% support |
| UnitedHealth Group Incorporated | 2026-06-01 | Shareholder If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. | For | AGAINST — 40 of 40 T. Rowe Price funds | Against | Not approved, 20.3% support |
| Morgan Stanley | 2026-05-14 | To approve the compensation of executives as disclosed in the proxy statement (non-binding advisory vote) | Against | FOR — 38 of 38 T. Rowe Price funds | Against | Passed (calculated), 95.8% support |
| Netflix, Inc. | 2026-06-04 | Advisory approval of named executive officer compensation. | Against | FOR — 39 of 39 T. Rowe Price funds | Against | Approved, 83.7% support |
| Visa Inc. | 2026-01-27 | Shareholder Shareholder proposal requesting the Board of Directors to adopt a policy for an independent chair. | For | AGAINST — 34 of 34 T. Rowe Price funds | Against | Not approved, 16.2% support |
| The Home Depot, Inc. | 2026-05-21 | Advisory Vote to Approve Executive Compensation ("Say-on-Pay") | Against | FOR — 34 of 34 T. Rowe Price funds | Against | Approved, 93.8% support |
| Philip Morris International Inc. | 2026-05-06 | Advisory Vote Approving Executive Compensation | Against | FOR — 36 of 36 T. Rowe Price funds | Against | Approved, 95.9% support |
| Linde Plc | 2025-07-29 | To approve, on an advisory and non-binding basis, the compensation of Linde plc's Named Executive Officers, as disclosed in the 2025 Proxy statement. | Against | FOR — 34 of 34 T. Rowe Price funds | Against | Approved, 94.1% support |
| Intuitive Surgical, Inc. | 2026-04-30 | To approve, by advisory vote, the compensation of the Company's Named Executive Officers. | Against | FOR — 34 of 34 T. Rowe Price funds | Against | Approved, 94.0% support |
| Booking Holdings Inc. | 2026-06-02 | Advisory vote to approve 2025 executive compensation. | Against | FOR — 34 of 34 T. Rowe Price funds | Against | Approved, 90.2% support |
| CME Group Inc. | 2026-06-09 | Advisory vote on the compensation of our named executive officers. | Against | FOR — 33 of 33 T. Rowe Price funds | Against | — |
| Marsh & McLennan Companies, Inc. | 2026-05-21 | Advisory (Nonbinding) Vote to Approve Named Executive Officer Compensation | Against | FOR — 35 of 35 T. Rowe Price funds | Against | Approved, 88.5% support |
| Tesla, Inc. | 2025-11-06 | A Tesla proposal for a non-binding advisory vote approving 2024 executive compensation. | Against | FOR — 32 of 32 T. Rowe Price funds | Against | Approved, 78.7% support |
| Deere & Company | 2026-02-25 | Advisory vote to approve executive compensation ("say-on-pay") | Against | FOR — 31 of 31 T. Rowe Price funds | Against | Approved, 92.2% support |
| ServiceNow, Inc. | 2026-05-21 | Advisory vote to approve ServiceNow's named executive officer compensation. | Against | FOR — 31 of 31 T. Rowe Price funds | Against | Passed (calculated), 85.5% support |
| Company | Meeting | Item | This fund | Most T. Rowe Price funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Amazon.com, Inc. | 2026-05-20 | Shareholder SHAREHOLDER PROPOSAL REQUESTING A MANDATORY INDEPENDENT BOARD CHAIR POLICY | For | AGAINST — 41 of 42 T. Rowe Price funds | Against | Not approved, 14.2% support |
| Tesla, Inc. | 2025-11-06 | A Tesla proposal for approval of the A&R 2019 Equity Incentive Plan. | Against | FOR — 28 of 28 T. Rowe Price funds | Against | Approved, 79.1% support |
| Tesla, Inc. | 2025-11-06 | A Tesla proposal to elect three Class III directors to serve for a term of three years, or until their respective successors are duly elected and qualified: Joe Gebbia | Against | FOR — 28 of 28 T. Rowe Price funds | Against | Elected, 87.3% support |
| Tesla, Inc. | 2025-11-06 | A Tesla proposal to elect three Class III directors to serve for a term of three years, or until their respective successors are duly elected and qualified: Kathleen Wilson-Thompson | Against | FOR — 28 of 28 T. Rowe Price funds | Against | Elected, 78.4% support |
| GE Vernova Inc. | 2026-05-20 | Approve the compensation of our named executive officers in an advisory vote | Against | FOR — 28 of 28 T. Rowe Price funds | Against | Approved, 96.0% support |
| Amphenol Corporation | 2026-05-21 | Advisory vote to approve compensation of named executive officers | Against | FOR — 28 of 28 T. Rowe Price funds | Against | — |
| Analog Devices, Inc. | 2026-03-11 | Advisory vote to approve the compensation of our named executive officers. | Against | FOR — 28 of 28 T. Rowe Price funds | Against | Approved, 90.3% support |
| The TJX Companies, Inc. | 2026-06-09 | Advisory approval of TJX's executive compensation (the say-on-pay vote) | Against | FOR — 25 of 25 T. Rowe Price funds | Against | Approved, 92.8% support |
| The Sherwin-Williams Company | 2026-04-22 | Advisory Approval of the Compensation of the Named Executive Officers | Against | FOR — 26 of 26 T. Rowe Price funds | Against | Approved, 92.2% support |
| TransDigm Group Incorporated | 2026-03-05 | Approval, on an advisory basis, of the compensation of our named executive officers. | Against | FOR — 25 of 25 T. Rowe Price funds | Against | Passed (calculated), 96.8% support |
| TE Connectivity plc | 2026-03-11 | An advisory vote to approve named executive officer compensation. | Against | FOR — 39 of 40 T. Rowe Price funds | Against | Passed (calculated), 92.1% support |
| Walmart Inc. | 2026-06-04 | Advisory Vote to Approve Named Executive Officer Compensation | Against | FOR — 23 of 23 T. Rowe Price funds | Against | Passed (calculated), 96.1% support |
| Palantir Technologies Inc. | 2026-06-03 | Shareholder Stockholder proposal entitled "Political Spending Disclosure," if properly presented at the Annual Meeting. | Against | FOR — 23 of 23 T. Rowe Price funds | For | Not approved, 26.2% support |
| The Progressive Corporation | 2026-05-08 | Cast an advisory vote to approve our executive compensation program; | Against | FOR — 24 of 24 T. Rowe Price funds | Against | — |
| McKesson Corporation | 2025-07-30 | Advisory Vote to Approve the Company's Executive Compensation | Against | FOR — 23 of 23 T. Rowe Price funds | Against | Approved, 92.0% support |
| AppLovin Corporation | 2026-06-03 | Approval of an amendment to our amended and restated certificate of incorporation to provide for officer exculpation as permitted by Delaware law. | Against | FOR — 23 of 23 T. Rowe Price funds | Against | Approved, 90.1% support |
| Intuit Inc. | 2026-01-22 | Advisory vote to approve Intuit's executive compensation (say-on-pay) | Against | FOR — 23 of 23 T. Rowe Price funds | Against | Passed (calculated), 93.2% support |
| Moody's Corporation | 2026-04-14 | Advisory resolution approving executive compensation. | Against | FOR — 23 of 23 T. Rowe Price funds | Against | Approved, 96.6% support |
| Northrop Grumman Corporation | 2026-05-20 | Proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers. | Against | FOR — 24 of 24 T. Rowe Price funds | Against | Approved, 95.4% support |
| Cencora, Inc. | 2026-03-05 | Advisory vote to approve the fiscal 2025 compensation of Cencora, Inc.'s named executive officers. | Against | FOR — 35 of 36 T. Rowe Price funds | Against | Approved, 93.2% support |
| TechnipFMC plc | 2026-05-01 | 2025 U.S. Say-on-Pay for Named Executive Officers: To approve, as a non-binding advisory resolution, the Company's named executive officer compensation for the year ended December 31, 2025, as reported in the Company's Proxy Statement. | Against | FOR — 35 of 36 T. Rowe Price funds | Against | — |
| Morgan Stanley | 2026-05-14 | Shareholder Shareholder proposal requesting an independent Board Chairman | For | AGAINST — 32 of 33 T. Rowe Price funds | Against | Failed (calculated), 27.3% support |
| QUALCOMM Incorporated | 2026-03-17 | Approval, on an advisory basis, of the compensation of our named executive officers. | Against | FOR — 21 of 21 T. Rowe Price funds | Against | Approved, 91.8% support |
| KLA Corporation | 2025-11-05 | To approve on a non-binding, advisory basis our named executive officer compensation. | Against | FOR — 21 of 21 T. Rowe Price funds | Against | Approved, 92.4% support |
| The Boeing Company | 2026-04-17 | Approve, on an Advisory Basis, Named Executive Officer Compensation. | Against | FOR — 22 of 22 T. Rowe Price funds | Against | Passed (calculated), 89.7% support |
| Parker-Hannifin Corporation | 2025-10-22 | Approval of, on a non-binding, advisory basis, the compensation of our Named Executive Officers. | Against | FOR — 22 of 22 T. Rowe Price funds | Against | Approved, 88.0% support |
| Synopsys, Inc. | 2026-04-16 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the attached Proxy Statement. | Against | FOR — 22 of 22 T. Rowe Price funds | Against | Approved, 91.5% support |
| The Allstate Corporation | 2026-05-22 | Advisory vote to approve the compensation of the named executives. | Against | FOR — 32 of 33 T. Rowe Price funds | Against | Passed (calculated), 92.7% support |
| Monolithic Power Systems, Inc. | 2026-06-11 | Approve, on an advisory basis, the 2025 executive compensation. | Against | FOR — 32 of 33 T. Rowe Price funds | Against | Passed (calculated), 96.8% support |
| Spotify Technology SA | 2026-04-15 | Approve Remuneration of Directors | Against | FOR — 20 of 20 T. Rowe Price funds | Against | — |
| TechnipFMC plc | 2026-05-01 | 2025 U.K. Directors' Remuneration Report: To approve, as a non-binding advisory resolution, the Company's directors' remuneration report for the year ended December 31, 2025, as reported in the Company's U.K. Annual Report and Accounts. | Against | FOR — 30 of 31 T. Rowe Price funds | Against | — |
| PTC Inc. | 2026-02-11 | Advisory vote to approve the compensation of our named executive officers (say-on-pay). | Against | FOR — 30 of 31 T. Rowe Price funds | Against | — |
| Broadcom Inc. | 2026-04-20 | Advisory vote to approve the named executive officer compensation. | Against | FOR — 46 of 49 T. Rowe Price funds | Against | Approved, 66.4% support |
| The Home Depot, Inc. | 2026-05-21 | Shareholder Shareholder Proposal Regarding Independent Board Chair | For | AGAINST — 28 of 29 T. Rowe Price funds | Against | Not approved, 26.0% support |
| Ross Stores, Inc. | 2026-05-20 | Advisory vote to approve the resolution on the compensation of the named executive officers. | Against | FOR — 29 of 30 T. Rowe Price funds | Against | Passed (calculated), 92.6% support |
| Natera, Inc. | 2026-06-11 | To approve an amendment to Natera's 2015 Equity Incentive Plan, as amended and restated. | Against | FOR — 29 of 30 T. Rowe Price funds | Against | Passed (calculated), 78.1% support |
| Chipotle Mexican Grill, Inc. | 2026-06-11 | An advisory vote to approve the compensation of our executive officers as disclosed in the proxy statement ("say on pay"). | Against | FOR — 29 of 30 T. Rowe Price funds | Against | Approved, 95.3% support |
| Tradeweb Markets Inc. | 2026-05-19 | To approve, on an advisory basis, the compensation of our named executive officers. | Against | FOR — 28 of 29 T. Rowe Price funds | Against | Approved, 98.7% support |
| Tenet Healthcare Corporation | 2026-05-27 | To vote, on an advisory basis, to approve the Company's executive compensation. | Against | FOR — 28 of 29 T. Rowe Price funds | Against | — |
| Accenture Plc | 2026-01-28 | To approve, in a non-binding vote, the compensation of our named executive officers. | Against | FOR — 18 of 18 T. Rowe Price funds | Against | — |
| Vertex Pharmaceuticals Incorporated | 2026-05-13 | Advisory vote to approve named executive officer compensation. | Against | FOR — 17 of 17 T. Rowe Price funds | Against | Approved, 93.5% support |
| Corning Incorporated | 2026-04-30 | Advisory approval of our executive compensation (Say on Pay) | Against | FOR — 18 of 18 T. Rowe Price funds | Against | Passed (calculated), 94.0% support |
| Motorola Solutions, Inc. | 2026-05-18 | Advisory Approval of the Company's Executive Compensation. | Against | FOR — 17 of 17 T. Rowe Price funds | Against | Approved, 91.5% support |
| Packaging Corporation of America | 2026-05-12 | Proposal to approve our executive compensation. | Against | FOR — 26 of 27 T. Rowe Price funds | Against | — |
| Carvana Co. | 2026-05-05 | Shareholder To vote upon one stockholder proposal, as described in the Proxy Statement. | For | AGAINST — 25 of 26 T. Rowe Price funds | Against | Not approved, 3.9% support |
| Datadog, Inc. | 2026-06-15 | Advisory vote to approve the compensation of our named executive officers. | Against | FOR — 25 of 26 T. Rowe Price funds | Against | Approved, 95.9% support |
| Ulta Beauty, Inc. | 2026-06-09 | Advisory resolution to approve the Company's executive compensation. | Against | FOR — 25 of 26 T. Rowe Price funds | Against | Approved, 77.9% support |
| Equifax Inc. | 2026-05-07 | Advisory vote to approve named executive officer compensation ("say-on-pay"). | Against | FOR — 25 of 26 T. Rowe Price funds | Against | Approved, 84.3% support |
| BrightSpring Health Services, Inc. | 2026-05-21 | Advisory vote on executive compensation | Against | FOR — 25 of 26 T. Rowe Price funds | Against | Approved, 98.7% support |
| Vaxcyte, Inc. | 2026-06-15 | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. | Against | FOR — 25 of 26 T. Rowe Price funds | Against | Approved, 97.9% support |
| Palo Alto Networks, Inc. | 2025-12-09 | To approve, on an advisory basis, the compensation of our named executive officers. | Against | FOR — 15 of 15 T. Rowe Price funds | Against | Failed (calculated), 46.6% support |
| Hilton Worldwide Holdings Inc. | 2026-05-14 | Approval, in a non-binding advisory vote, of the compensation paid to the named executive officers. | Against | FOR — 24 of 25 T. Rowe Price funds | Against | Approved, 92.6% support |
| Vertiv Holdings Co. | 2026-06-17 | To approve, on an advisory basis, the 2025 compensation of our named executive officers as disclosed in the Proxy Statement. | Against | FOR — 24 of 25 T. Rowe Price funds | Against | Approved, 88.4% support |
| Quest Diagnostics Incorporated | 2026-05-20 | An advisory resolution to approve the executive officer compensation disclosed in the Company's 2026 proxy statement. | Against | FOR — 24 of 25 T. Rowe Price funds | Against | Approved, 92.4% support |
| HubSpot, Inc. | 2026-06-15 | Non-binding advisory vote to approve the compensation of the Company's named executive officers; | Against | FOR — 24 of 25 T. Rowe Price funds | Against | Approved, 90.2% support |
| Repligen Corporation | 2026-05-14 | Election of Directors: Carrie Eglinton Manner | Against | FOR — 22 of 23 T. Rowe Price funds | Against | Elected, 81.0% support |
| Repligen Corporation | 2026-05-14 | Election of Directors: Glenn P. Muir | Against | FOR — 22 of 23 T. Rowe Price funds | Against | Elected, 74.4% support |
| Repligen Corporation | 2026-05-14 | Election of Directors: Karen A. Dawes | Against | FOR — 22 of 23 T. Rowe Price funds | Against | Elected, 82.4% support |
| BlackRock, Inc. | 2026-05-20 | Approval, in a non-binding advisory vote, of the compensation for named executive officers. | Against | FOR — 14 of 14 T. Rowe Price funds | Against | Passed (calculated), 65.0% support |
| Automatic Data Processing, Inc. | 2025-11-12 | Advisory Vote on Executive Compensation. | Against | FOR — 14 of 14 T. Rowe Price funds | Against | Approved, 91.8% support |
| Vertiv Holdings Co. | 2026-06-17 | Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: David M. Cote | Withhold | FOR — 21 of 22 T. Rowe Price funds | Against | Passed (calculated), 90.4% support |
| Vertiv Holdings Co. | 2026-06-17 | Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: Edward L. Monser | Withhold | FOR — 21 of 22 T. Rowe Price funds | Against | Passed (calculated), 82.9% support |
| Vertiv Holdings Co. | 2026-06-17 | Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: Giordano Albertazzi | Withhold | FOR — 21 of 22 T. Rowe Price funds | Against | Passed (calculated), 97.5% support |
| Vertiv Holdings Co. | 2026-06-17 | Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: Jakki L. Haussler | Withhold | FOR — 21 of 22 T. Rowe Price funds | Against | Passed (calculated), 96.0% support |
| Vertiv Holdings Co. | 2026-06-17 | Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: Joseph J. DeAngelo | Withhold | FOR — 21 of 22 T. Rowe Price funds | Against | Passed (calculated), 74.9% support |
| Vertiv Holdings Co. | 2026-06-17 | Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: Roger Fradin | Withhold | FOR — 21 of 22 T. Rowe Price funds | Against | Passed (calculated), 70.3% support |
| Vertiv Holdings Co. | 2026-06-17 | Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: Steven S. Reinemund | Withhold | FOR — 21 of 22 T. Rowe Price funds | Against | Passed (calculated), 76.6% support |
| Boston Scientific Corporation | 2026-04-30 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. | Against | FOR — 14 of 14 T. Rowe Price funds | Against | Approved, 90.8% support |
| Zoetis Inc. | 2026-05-20 | Advisory vote to approve our executive compensation. | Against | FOR — 14 of 14 T. Rowe Price funds | Against | Approved, 85.6% support |
| Micron Technology, Inc. | 2026-01-15 | PROPOSAL BY THE COMPANY TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DESCRIBED IN THE PROXY STATEMENT. | Against | FOR — 13 of 13 T. Rowe Price funds | Against | Approved, 95.1% support |
| Trane Technologies plc | 2026-06-04 | Advisory approval of the compensation of the Company's named executive officers. | Against | FOR — 13 of 13 T. Rowe Price funds | Against | Passed (calculated), 88.4% support |
| Cadence Design Systems, Inc. | 2026-05-07 | ADVISORY RESOLUTION TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION | Against | FOR — 13 of 13 T. Rowe Price funds | Against | Approved, 86.9% support |
| Cheniere Energy, Inc. | 2026-05-14 | Approve, on an advisory and non-binding basis, the compensation of the Company's named executive officers for 2025. | Against | FOR — 20 of 21 T. Rowe Price funds | Against | Passed (calculated), 90.7% support |
| Ventas, Inc. | 2026-05-13 | Approval, on an advisory basis, of the compensation of named executive officers of Ventas, Inc. | Against | FOR — 20 of 21 T. Rowe Price funds | Against | Passed (calculated), 91.7% support |
| Quest Diagnostics Incorporated | 2026-05-20 | Shareholder Stockholder proposal regarding an independent board chairman, if properly presented at the Annual Meeting. | For | AGAINST — 20 of 21 T. Rowe Price funds | Against | Not approved, 25.6% support |
| Broadridge Financial Solutions, Inc. | 2025-11-13 | Advisory vote to approve the compensation of the Company's Named Executive Officers (the Say on Pay Vote); | Against | FOR — 20 of 21 T. Rowe Price funds | Against | Passed (calculated), 91.6% support |
| Elanco Animal Health Incorporated | 2026-05-21 | Advisory vote on the compensation of the company's named executive officers. | Against | FOR — 20 of 21 T. Rowe Price funds | Against | Approved, 82.0% support |
| Ecolab Inc. | 2026-05-07 | Approve, on an advisory basis, the compensation of our named executive officers disclosed in the Proxy Statement. | Against | FOR — 12 of 12 T. Rowe Price funds | Against | Approved, 94.0% support |
| Northrop Grumman Corporation | 2026-05-20 | Shareholder Shareholder proposal to provide for an independent Board chair. | For | AGAINST — 19 of 20 T. Rowe Price funds | Against | Not approved, 21.0% support |
| Autodesk, Inc. | 2026-06-17 | Approve, on an advisory (non-binding) basis, the compensation of Autodesk, Inc.'s named executive officers. | Against | FOR — 12 of 12 T. Rowe Price funds | Against | Passed (calculated), 91.7% support |
| Tractor Supply Company | 2026-05-14 | To approve, on a non-binding, advisory basis, the compensation of the named executive officers of the Company (Say on Pay) | Against | FOR — 19 of 20 T. Rowe Price funds | Against | Approved, 86.0% support |
| Burlington Stores, Inc. | 2026-05-19 | Approval, on a non-binding advisory basis, of the compensation of Burlington Stores, Inc.'s named executive officers ("Say-On-Pay") | Against | FOR — 19 of 20 T. Rowe Price funds | Against | Passed (calculated), 88.0% support |
| Howmet Aerospace Inc. | 2026-05-19 | Advisory vote to approve executive compensation. | Against | FOR — 18 of 19 T. Rowe Price funds | Against | Approved, 71.1% support |
| Cardinal Health, Inc. | 2025-11-05 | To approve, on a non-binding advisory basis, the compensation of our named executive officers | Against | FOR — 18 of 19 T. Rowe Price funds | Against | Approved, 90.7% support |
| MSCI Inc. | 2026-04-21 | To approve, by advisory vote, our executive compensation. | Against | FOR — 18 of 19 T. Rowe Price funds | Against | Approved, 93.6% support |
| Charles River Laboratories International, Inc. | 2026-05-05 | Advisory Approval of 2025 Executive Officer Compensation | Against | FOR — 18 of 19 T. Rowe Price funds | Against | Approved, 93.8% support |
| RBC Bearings Incorporated | 2025-09-04 | To consider a resolution regarding the stockholder advisory vote on named executive officer compensation. | Against | FOR — 18 of 19 T. Rowe Price funds | Against | Approved, 81.1% support |
| Thermo Fisher Scientific Inc. | 2026-05-20 | An advisory vote to approve named executive officer compensation. | Against | FOR — 36 of 41 T. Rowe Price funds | Against | Not approved, 31.8% support |
| Lam Research Corporation | 2025-11-04 | Advisory vote to approve the compensation of the named executive officers of Lam Research, or "Say on Pay." | Against | FOR — 11 of 11 T. Rowe Price funds | Against | — |
| Arthur J. Gallagher & Co. | 2026-05-12 | Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers. | Against | FOR — 11 of 11 T. Rowe Price funds | Against | — |
| CBRE Group, Inc. | 2026-05-21 | Advisory vote to approve named executive officer compensation for 2025. | Against | FOR — 17 of 18 T. Rowe Price funds | Against | — |
| Revolution Medicines, Inc. | 2026-06-18 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). | Against | FOR — 17 of 18 T. Rowe Price funds | Against | Approved, 96.5% support |
| Insmed Incorporated | 2026-05-13 | An advisory vote on the 2025 compensation of our named executive officers. | Against | FOR — 17 of 18 T. Rowe Price funds | Against | Approved, 87.3% support |
| Paylocity Holding Corporation | 2025-12-04 | Advisory vote to approve the compensation of named executive officers. | Against | FOR — 17 of 18 T. Rowe Price funds | Against | Passed (calculated), 93.3% support |
| Ferrari NV | 2026-04-15 | Reelect John Elkann as Executive Director | Against | FOR — 11 of 11 T. Rowe Price funds | Against | — |
| The Bank of New York Mellon Corporation | 2026-04-14 | Advisory resolution to approve the 2025 compensation of our named executive officers. | Against | FOR — 16 of 17 T. Rowe Price funds | Against | Passed (calculated), 55.6% support |
| Alnylam Pharmaceuticals, Inc. | 2026-05-20 | To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers. | Against | FOR — 16 of 17 T. Rowe Price funds | Against | — |
| HCA Healthcare, Inc. | 2026-04-23 | Advisory vote to approve named executive officer compensation. | Against | FOR — 10 of 10 T. Rowe Price funds | Against | Approved, 93.5% support |
| Snowflake Inc. | 2026-06-29 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. | Against | FOR — 10 of 10 T. Rowe Price funds | Against | Not approved, 43.6% support |
| Westinghouse Air Brake Technologies Corporation | 2026-05-12 | Approve an advisory (non-binding) resolution to approve the 2025 named executive officer compensation. | Against | FOR — 15 of 16 T. Rowe Price funds | Against | Approved, 92.3% support |
| Live Nation Entertainment, Inc. | 2026-06-11 | To hold an advisory vote on the company's executive compensation; | Against | FOR — 15 of 16 T. Rowe Price funds | Against | Passed (calculated), 86.8% support |
| Rockwell Automation, Inc. | 2026-02-10 | To approve, on an advisory basis, the compensation of the Corporation's named executive officers. | Against | FOR — 15 of 16 T. Rowe Price funds | Against | Approved, 87.2% support |
| United Therapeutics Corporation | 2026-06-26 | Advisory resolution to approve executive compensation. | Against | FOR — 15 of 16 T. Rowe Price funds | Against | Passed (calculated), 97.1% support |
| Invesco Ltd. | 2026-05-21 | Advisory vote to approve the company's 2025 executive compensation. | Against | FOR — 15 of 16 T. Rowe Price funds | Against | Approved, 98.6% support |
| SiTime Corporation | 2026-05-29 | To approve, on an advisory basis, the compensation of SiTime's named executive officers as disclosed in SiTime's proxy statement. | Against | FOR — 15 of 16 T. Rowe Price funds | Against | Approved, 82.1% support |
| KKR & Co. Inc. | 2026-05-21 | An amendment to the Existing Charter to establish stockholders' meetings as the sole mechanism for approval of matters on which holders of common stock are required or permitted to vote. | Against | FOR — 14 of 15 T. Rowe Price funds | Against | — |
| KKR & Co. Inc. | 2026-05-21 | An amendment to the Existing Charter to grant the Board the sole authority to fill board vacancies and newly created directorships. | Against | FOR — 14 of 15 T. Rowe Price funds | Against | — |
| KKR & Co. Inc. | 2026-05-21 | Other amendments to the Existing Charter to modernize and streamline the Existing Charter. | Against | FOR — 14 of 15 T. Rowe Price funds | Against | — |
| Ecolab Inc. | 2026-05-07 | Shareholder Vote on a stockholder proposal regarding an independent board chair policy, if properly presented at the meeting. | For | AGAINST — 9 of 9 T. Rowe Price funds | Against | Not approved, 26.0% support |
| Veeva Systems Inc. | 2026-06-17 | To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Gordon Ritter | Against | FOR — 14 of 15 T. Rowe Price funds | Against | Elected, 73.6% support |
| Veeva Systems Inc. | 2026-06-17 | To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Mark Carges | Against | FOR — 14 of 15 T. Rowe Price funds | Against | Elected, 80.0% support |
| MongoDB, Inc. | 2026-06-30 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers. | Against | FOR — 14 of 15 T. Rowe Price funds | Against | Approved, 89.2% support |
| UL Solutions Inc. | 2026-05-20 | The approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the Proxy Statement. | Against | FOR — 14 of 15 T. Rowe Price funds | Against | Passed (calculated), 99.9% support |
| Dynatrace, Inc. | 2025-08-20 | Non-binding advisory vote on the compensation of Dynatrace's named executive officers. | Against | FOR — 14 of 15 T. Rowe Price funds | Against | Approved, 91.6% support |
| Targa Resources Corp. | 2026-05-21 | To approve, on an advisory basis, the compensation of the Company's named executive officers for the fiscal year ended December 31, 2025. | Against | FOR — 13 of 14 T. Rowe Price funds | Against | Approved, 95.3% support |
| Mueller Industries, Inc. | 2026-05-07 | To approve, on an advisory basis by non-binding vote, executive compensation. | Against | FOR — 13 of 14 T. Rowe Price funds | Against | Approved, 95.3% support |
| Eli Lilly and Company | 2026-05-04 | Shareholder Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. | For | AGAINST — 33 of 40 T. Rowe Price funds | Against | Not approved, 33.7% support |
| eBay Inc. | 2026-06-17 | Advisory vote to approve named executive officer compensation. | Against | FOR — 12 of 13 T. Rowe Price funds | Against | Approved, 88.1% support |
| Ferguson Enterprises Inc. | 2026-04-30 | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers for the five-month transition period from August 1, 2025 to December 31, 2025. | Against | FOR — 12 of 13 T. Rowe Price funds | Against | Passed (calculated), 92.4% support |
| United Airlines Holdings, Inc. | 2026-05-19 | A vote to approve, on a nonbinding advisory basis, the compensation of our named executive officers. | Against | FOR — 12 of 13 T. Rowe Price funds | Against | Approved, 94.3% support |
| Samsara Inc. | 2025-07-29 | The approval, on a non-binding advisory basis, of the compensation of Samsara Inc.'s named executive officers. | Against | FOR — 12 of 13 T. Rowe Price funds | Against | Approved, 98.6% support |
| United Therapeutics Corporation | 2026-06-26 | Approval of the United Therapeutics Corporation 2026 Stock Incentive Plan. | Against | FOR — 12 of 13 T. Rowe Price funds | Against | Passed (calculated), 72.0% support |
| Permian Resources Corporation | 2026-05-19 | To approve the First Amendment to the Permian Resources Corporation 2023 Long Term Incentive Plan. | Against | FOR — 12 of 13 T. Rowe Price funds | Against | Passed (calculated), 71.8% support |
| BJ's Wholesale Club Holdings, Inc. | 2026-06-18 | Approve, on an advisory (non-binding) basis, the compensation of the named executive officers of BJ's Wholesale Club Holdings, Inc. | Against | FOR — 12 of 13 T. Rowe Price funds | Against | Approved, 93.0% support |
| BWX Technologies, Inc. | 2026-04-30 | Advisory vote on compensation of our Named Executive Officers. | Against | FOR — 12 of 13 T. Rowe Price funds | Against | Passed (calculated), 98.5% support |
| IDEXX Laboratories, Inc. | 2026-05-12 | Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three). | Against | FOR — 11 of 12 T. Rowe Price funds | Against | — |
| Vistra Corp. | 2026-04-29 | To approve, on a non-binding advisory basis, the 2025 compensation of the Company's named executive officers. | Against | FOR — 11 of 12 T. Rowe Price funds | Against | Approved, 96.9% support |
| Circle Internet Group, Inc. | 2026-05-14 | Advisory Vote to Approve Named Executive Officer Compensation | Against | FOR — 7 of 7 T. Rowe Price funds | Against | Approved, 99.1% support |
| Tradeweb Markets Inc. | 2026-05-19 | Election of Directors: Catherine Johnson | Withhold | FOR — 20 of 24 T. Rowe Price funds | Against | Elected, 97.4% support |
| Tradeweb Markets Inc. | 2026-05-19 | Election of Directors: Daniel Maguire | Withhold | FOR — 20 of 24 T. Rowe Price funds | Against | Elected, 97.4% support |
| Tradeweb Markets Inc. | 2026-05-19 | Election of Directors: Scott Ganeles | Withhold | FOR — 20 of 24 T. Rowe Price funds | Against | Elected, 96.9% support |
| Royal Caribbean Cruises Ltd. | 2026-05-28 | Advisory approval of the Company's compensation of its named executive officers. | Against | FOR — 10 of 11 T. Rowe Price funds | Against | Passed (calculated), 96.8% support |
| Quanta Services, Inc. | 2026-05-21 | Approval, by non-binding advisory vote, of the compensation of Quanta's named executive officers for fiscal year 2025; | Against | FOR — 10 of 11 T. Rowe Price funds | Against | — |
| Everpure, Inc. | 2026-06-10 | An advisory vote on our named executive officer compensation. | Against | FOR — 10 of 11 T. Rowe Price funds | Against | Approved, 90.4% support |
| Tapestry, Inc. | 2025-11-13 | Advisory vote to approve the Company's executive compensation, as discussed and described in the proxy statement. | Against | FOR — 10 of 11 T. Rowe Price funds | Against | Passed (calculated), 89.9% support |
| Nutanix, Inc. | 2025-12-12 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers. | Against | FOR — 10 of 11 T. Rowe Price funds | Against | Approved, 92.1% support |
| Fair Isaac Corporation | 2026-03-04 | To approve the advisory (non-binding) resolution relating to the named executive officer compensation as disclosed in the proxy statement. | Against | FOR — 10 of 11 T. Rowe Price funds | Against | Approved, 84.9% support |
| Vertiv Holdings Co. | 2026-06-17 | Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: Matthew Louie | Withhold | FOR — 18 of 22 T. Rowe Price funds | Against | Passed (calculated), 85.6% support |
| Tesla, Inc. | 2025-11-06 | A Tesla proposal for approval of the 2025 CEO Performance Award. | Against | FOR — 22 of 28 T. Rowe Price funds | Against | Approved, 77.0% support |
| Roblox Corporation | 2026-05-28 | Advisory Vote on the Compensation of our Named Executive Officers. | Against | FOR — 12 of 14 T. Rowe Price funds | Against | Passed (calculated), 84.2% support |
| NRG Energy, Inc. | 2026-04-30 | To approve, on a non-binding advisory basis, NRG Energy, Inc.'s executive compensation. | Against | FOR — 9 of 10 T. Rowe Price funds | Against | — |
| Insulet Corporation | 2026-05-20 | To approve, on a non-binding, advisory basis, the compensation of certain executive officers. | Against | FOR — 9 of 10 T. Rowe Price funds | Against | Passed (calculated), 92.0% support |
| Corpay, Inc. | 2026-05-07 | Shareholder Shareholder proposal regarding an independent Board Chair requirement, if properly presented at the meeting. | For | AGAINST — 15 of 19 T. Rowe Price funds | Against | Failed (calculated), 30.0% support |
| SharkNinja, Inc. | 2026-06-18 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. | Against | FOR — 8 of 9 T. Rowe Price funds | Against | Approved, 92.6% support |
| CDW Corporation | 2026-05-21 | To approve, on an advisory basis, named executive officer compensation. | Against | FOR — 8 of 9 T. Rowe Price funds | Against | Approved, 91.1% support |
| Manhattan Associates, Inc. | 2026-05-14 | Non-binding resolution to approve the compensation of the Company's named executive officers. | Against | FOR — 8 of 9 T. Rowe Price funds | Against | Approved, 89.5% support |
| Procore Technologies, Inc. | 2026-06-04 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers | Against | FOR — 8 of 9 T. Rowe Price funds | Against | Approved, 63.1% support |
| Ameriprise Financial, Inc. | 2026-04-29 | To approve the compensation of the named executive officers by a nonbinding advisory vote. | Against | FOR — 7 of 8 T. Rowe Price funds | Against | Approved, 90.6% support |
| Take-Two Interactive Software, Inc. | 2025-09-18 | Approval of an amendment and restatement of the Amended and Restated Take-Two Interactive Software, Inc. 2017 Stock Incentive Plan. | Against | FOR — 7 of 8 T. Rowe Price funds | Against | Approved, 77.6% support |
| Interactive Brokers Group, Inc. | 2026-04-23 | To approve, by non-binding vote, executive compensation. | Against | FOR — 7 of 8 T. Rowe Price funds | Against | Passed (calculated), 98.1% support |
| Medpace Holdings, Inc. | 2026-05-15 | To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting. | Against | FOR — 7 of 8 T. Rowe Price funds | Against | — |
| Stifel Financial Corp. | 2026-06-09 | To approve, on an advisory basis, the compensation of our named executive officers (say on pay). | Against | FOR — 7 of 8 T. Rowe Price funds | Against | Passed (calculated), 98.1% support |
| Lazard, Inc. | 2026-05-21 | Approval of the amendment to the Lazard Inc. 2018 Incentive Compensation Plan. | Against | FOR — 7 of 8 T. Rowe Price funds | Against | Passed (calculated), 60.9% support |
| Stride, Inc. | 2025-12-04 | Approval, on a non-binding advisory basis, of the compensation of the named executive officers of the Company; | Against | FOR — 7 of 8 T. Rowe Price funds | Against | Approved, 81.9% support |
| Corning Incorporated | 2026-04-30 | Shareholder Request to adopt an independent chair policy | For | AGAINST — 11 of 14 T. Rowe Price funds | Against | Not approved, 18.2% support |
| UL Solutions Inc. | 2026-05-20 | Election of Directors: Elisabeth Torstad | Withhold | FOR — 10 of 13 T. Rowe Price funds | Against | — |
| UL Solutions Inc. | 2026-05-20 | Election of Directors: George A. Williams | Withhold | FOR — 10 of 13 T. Rowe Price funds | Against | Elected, 99.7% support |
| UL Solutions Inc. | 2026-05-20 | Election of Directors: James M. Shannon | Withhold | FOR — 10 of 13 T. Rowe Price funds | Against | Elected, 99.8% support |
| UL Solutions Inc. | 2026-05-20 | Election of Directors: James P. Dollive | Withhold | FOR — 10 of 13 T. Rowe Price funds | Against | Elected, 99.6% support |
| UL Solutions Inc. | 2026-05-20 | Election of Directors: Marla C. Gottschalk | Withhold | FOR — 10 of 13 T. Rowe Price funds | Against | Elected, 99.8% support |
| UL Solutions Inc. | 2026-05-20 | Election of Directors: Sally Susman | Withhold | FOR — 10 of 13 T. Rowe Price funds | Against | Elected, 99.9% support |
| DexCom, Inc. | 2026-05-27 | To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2025. | Against | FOR — 6 of 7 T. Rowe Price funds | Against | Approved, 88.3% support |
| Williams-Sonoma, Inc. | 2026-06-18 | An advisory vote to approve executive compensation | Against | FOR — 6 of 7 T. Rowe Price funds | Against | Approved, 84.0% support |
| Rocket Lab Corporation | 2026-05-20 | Election of Class II Director Nominee: To be elected for term expiring in 2029: Edward H. Frank | For | WITHHOLD — 6 of 7 T. Rowe Price funds | For | Passed (calculated), 84.2% support |
| CDW Corporation | 2026-05-21 | Shareholder To consider and act upon the stockholder proposal, if properly presented at the meeting, regarding independent Board chair requirements. | For | AGAINST — 6 of 7 T. Rowe Price funds | Against | Not approved, 42.7% support |
| NRG Energy, Inc. | 2026-04-30 | Shareholder To vote on a stockholder proposal to give shareholders the ability to call for a special shareholder meeting, if properly presented at the meeting. | For | AGAINST — 6 of 7 T. Rowe Price funds | Against | Approved, 55.6% support |
| CACI International Inc. | 2025-10-16 | To approve on a non-binding, advisory basis the compensation of our named executive officers; | Against | FOR — 6 of 7 T. Rowe Price funds | Against | Approved, 94.8% support |
| JFrog Ltd. | 2026-05-20 | To approve on a nonbinding, advisory basis the compensation paid to us to our named executive officers, as disclosed in the proxy statement. | Against | FOR — 6 of 7 T. Rowe Price funds | Against | Passed (calculated), 82.0% support |
| Celsius Holdings, Inc. | 2026-05-28 | To elect as directors the ten nominees listed below to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Caroline Levy | For | AGAINST — 6 of 7 T. Rowe Price funds | For | Elected, 98.0% support |
| Celsius Holdings, Inc. | 2026-05-28 | To elect as directors the ten nominees listed below to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Cheryl Miller | For | AGAINST — 6 of 7 T. Rowe Price funds | For | Elected, 98.8% support |
| Celsius Holdings, Inc. | 2026-05-28 | To elect as directors the ten nominees listed below to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Damon DeSantis | For | AGAINST — 6 of 7 T. Rowe Price funds | For | Elected, 96.5% support |
| Celsius Holdings, Inc. | 2026-05-28 | To elect as directors the ten nominees listed below to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Hal Kravitz | For | AGAINST — 6 of 7 T. Rowe Price funds | For | Elected, 99.4% support |
| Celsius Holdings, Inc. | 2026-05-28 | To elect as directors the ten nominees listed below to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Joyce Russell | For | AGAINST — 6 of 7 T. Rowe Price funds | For | Elected, 97.3% support |
| Celsius Holdings, Inc. | 2026-05-28 | To elect as directors the ten nominees listed below to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Nick Castaldo | For | AGAINST — 6 of 7 T. Rowe Price funds | For | Elected, 97.7% support |
| Churchill Downs Incorporated | 2026-04-21 | To approve, on a non-binding advisory basis, the Company's executive compensation as disclosed in the proxy statement. | Against | FOR — 6 of 7 T. Rowe Price funds | Against | Approved, 84.7% support |
| Seagate Technology Holdings plc | 2025-10-25 | Approve, in an Advisory, Non-binding Vote, the Compensation of the Company's Named Executive Officers ("Say-on-Pay"). | Against | FOR — 5 of 6 T. Rowe Price funds | Against | — |
| BeOne Medicines Ltd. | 2026-06-11 | THAT, on a non-binding, advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, for the fiscal year ended December 31, 2025 be and is hereby approved. | Against | FOR — 5 of 6 T. Rowe Price funds | Against | Approved, 94.9% support |
| Iron Mountain Incorporated | 2026-05-07 | The approval of a non-binding, advisory resolution approving the compensation of our named executive officers as described in the Iron Mountain Incorporated Proxy Statement. | Against | FOR — 5 of 6 T. Rowe Price funds | Against | Approved, 96.7% support |
| Expedia Group, Inc. | 2026-06-17 | Approval, on an advisory basis, of the compensation of Expedia Group's named executive officers. | Against | FOR — 5 of 6 T. Rowe Price funds | Against | Approved, 89.4% support |
| Twilio Inc. | 2026-06-16 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. | Against | FOR — 5 of 6 T. Rowe Price funds | Against | Approved, 93.7% support |
| Celestica Inc. | 2026-05-19 | To approve, on an advisory basis, the compensation of Celestica Inc.'s named executive officers. | Against | FOR — 5 of 6 T. Rowe Price funds | Against | Passed (calculated), 96.4% support |
| Penumbra, Inc. | 2026-06-18 | To elect the nominees for Class II director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Arani Bose, M.D. | For | WITHHOLD — 3 of 3 T. Rowe Price funds | For | Elected, 84.9% support |
| Penumbra, Inc. | 2026-06-18 | To elect the nominees for Class II director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Bridget O'Rourke | For | WITHHOLD — 3 of 3 T. Rowe Price funds | For | Elected, 95.5% support |
| Penumbra, Inc. | 2026-06-18 | To elect the nominees for Class II director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Surbhi Sarna | For | WITHHOLD — 3 of 3 T. Rowe Price funds | For | Elected, 97.3% support |
| Stifel Financial Corp. | 2026-06-09 | To approve the adoption of an amendment to the Stifel Financial Corp. 2001 Incentive Stock Plan (2018 Restatement) | Against | FOR — 5 of 6 T. Rowe Price funds | Against | Passed (calculated), 69.2% support |
| Service Corporation International | 2026-05-06 | Election of Directors: Marcus A. Watts | For | AGAINST — 12 of 18 T. Rowe Price funds | For | Failed (calculated), 43.5% support |
| Service Corporation International | 2026-05-06 | To approve the 2026 Equity Incentive Plan. | Against | FOR — 12 of 18 T. Rowe Price funds | Against | Approved, 78.1% support |
| Rocket Companies, Inc. | 2026-06-10 | Election of Class III Directors: Varun Krishna | Withhold | FOR — 11 of 18 T. Rowe Price funds | Against | Passed (calculated), 87.9% support |
| HEICO Corporation | 2026-03-13 | ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Adolfo Henriques | For | AGAINST — 4 of 5 T. Rowe Price funds | For | Elected, 97.5% support |
| HEICO Corporation | 2026-03-13 | ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Carol F. Fine | For | AGAINST — 4 of 5 T. Rowe Price funds | For | Elected, 98.8% support |
| HEICO Corporation | 2026-03-13 | ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Dr. Alan Schriesheim | For | AGAINST — 4 of 5 T. Rowe Price funds | For | Elected, 73.2% support |
| HEICO Corporation | 2026-03-13 | ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Julie Neitzel | For | AGAINST — 4 of 5 T. Rowe Price funds | For | Elected, 98.4% support |
| HEICO Corporation | 2026-03-13 | ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Mark H. Hildebrandt | For | AGAINST — 4 of 5 T. Rowe Price funds | For | Elected, 73.7% support |
| HEICO Corporation | 2026-03-13 | ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Thomas M. Culligan | For | AGAINST — 4 of 5 T. Rowe Price funds | For | Elected, 98.3% support |
| BeOne Medicines Ltd. | 2026-06-11 | THAT Mr. John V. Oyler be and is hereby re-elected to serve as Chairman of the Board of Directors of the Company for a term extending until completion of the 2027 annual general meeting. | Against | FOR — 4 of 5 T. Rowe Price funds | Against | Elected, 98.8% support |
| BeOne Medicines Ltd. | 2026-06-11 | THAT, on an advisory basis, the Swiss Statutory Compensation Report for the fiscal year ended December 31, 2025 be and is hereby approved. | Against | FOR — 4 of 5 T. Rowe Price funds | Against | Approved, 95.6% support |
| BeOne Medicines Ltd. | 2026-06-11 | THAT, the maximum aggregate compensation for the Board of Directors for the period between the 2026 annual general meeting and the 2027 annual general meeting, be and is hereby approved. | Against | FOR — 4 of 5 T. Rowe Price funds | Against | Approved, 95.4% support |
| Carnival Corporation | 2026-04-17 | To hold a (non-binding) advisory vote to approve executive compensation. | Against | FOR — 4 of 5 T. Rowe Price funds | Against | Passed (calculated), 96.8% support |
| Okta, Inc. | 2026-06-18 | To approve an amendment to our 2017 Equity Incentive Plan. | Against | FOR — 4 of 5 T. Rowe Price funds | Against | Approved, 70.6% support |
| Hyatt Hotels Corporation | 2026-05-20 | Approval, on an advisory basis, of the compensation paid to our named executive officers as disclosed pursuant to the Securities and Exchange Commission's compensation disclosure rules. | Against | FOR — 4 of 5 T. Rowe Price funds | Against | Approved, 99.5% support |
| Somnigroup International, Inc. | 2026-05-13 | ADVISORY VOTE TO APPROVE THE COMPENSATION OF NAMED EXECUTIVE OFFICERS; AND | Against | FOR — 4 of 5 T. Rowe Price funds | Against | Passed (calculated), 58.1% support |
| Dutch Bros Inc. | 2026-05-13 | Election of Directors: Todd Penegor | For | AGAINST — 10 of 17 T. Rowe Price funds | For | Elected, 91.7% support |
| Dutch Bros Inc. | 2026-05-13 | Election of Directors: Travis Boersma | For | AGAINST — 10 of 17 T. Rowe Price funds | For | Elected, 95.6% support |
| Clean Harbors, Inc. | 2026-05-20 | To elect four (4) Class I members of the Board of Directors of the Company to serve until the 2029 Annual Meeting of Shareholders: John R. Welch | Withhold | FOR — 6 of 9 T. Rowe Price funds | Against | Passed (calculated), 98.5% support |
| Clean Harbors, Inc. | 2026-05-20 | To elect four (4) Class I members of the Board of Directors of the Company to serve until the 2029 Annual Meeting of Shareholders: Shelley Stewart, Jr. | Withhold | FOR — 6 of 9 T. Rowe Price funds | Against | Passed (calculated), 99.4% support |
| Domino's Pizza, Inc. | 2026-04-21 | Shareholder Shareholder proposal regarding an independent board chair requirement. | For | AGAINST — 7 of 12 T. Rowe Price funds | Against | Not approved, 39.9% support |
| Fastenal Company | 2026-04-23 | Shareholder Shareholder proposal relating to an EEO-1 reporting disclosure policy, if properly presented at the annual meeting. | Against | FOR — 3 of 4 T. Rowe Price funds | — | Not approved, 23.0% support |
| Carnival Corporation | 2026-04-17 | To hold a (non-binding) advisory vote to approve the Carnival plc Directors' Remuneration Report (in accordance with legal requirements applicable to UK companies). | Against | FOR — 3 of 4 T. Rowe Price funds | Against | Passed (calculated), 97.2% support |
| Hyatt Hotels Corporation | 2026-05-20 | Shareholder Stockholder proposal requesting the issuance of a report analyzing whether Hyatt could disclose its overall plastics use. | Against | FOR — 3 of 4 T. Rowe Price funds | For | Not approved, 0.4% support |
| Core & Main, Inc. | 2026-06-23 | Election of Directors: Bhavani Amirthalingam | For | WITHHOLD — 3 of 4 T. Rowe Price funds | For | Elected, 95.4% support |
| Core & Main, Inc. | 2026-06-23 | Election of Directors: Margaret M. Newman | For | WITHHOLD — 3 of 4 T. Rowe Price funds | For | Elected, 94.6% support |
| Core & Main, Inc. | 2026-06-23 | Election of Directors: Orvin T. Kimbrough | For | WITHHOLD — 3 of 4 T. Rowe Price funds | For | Elected, 64.2% support |
| Impinj, Inc. | 2026-05-28 | Election of Directors: Steve Sanghi | For | AGAINST — 7 of 13 T. Rowe Price funds | For | Elected, 68.1% support |
| Symbotic Inc. | 2026-03-05 | To approve an advisory vote on the compensation paid to our named executive officers. | Against | FOR — 2 of 3 T. Rowe Price funds | Against | Passed (calculated), 99.0% support |
Download all 239 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 94.7% of this fund’s 3,708 such votes could be given a sector; the other 197 (5.3%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Consumer Discretionary | 965 | 50 | 5.2% |
| Technology | 834 | 46 | 5.5% |
| Industrials | 515 | 16 | 3.1% |
| Health Care | 448 | 12 | 2.7% |
| Finance | 412 | 6 | 1.5% |
| Energy | 86 | 0 | 0.0% |
| Utilities | 84 | 1 | 1.2% |
| Real Estate | 66 | 0 | 0.0% |
| Miscellaneous | 37 | 0 | 0.0% |
| Consumer Staples | 30 | 0 | 0.0% |
| Basic Materials | 24 | 1 | 4.2% |
| Telecommunications | 10 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 2,659 | 0 |
| Audit-related | 336 | 0 |
| Say-on-Pay | 328 | 0 |
| Corporate Governance | 162 | 60 |
| Compensation | 107 | 3 |
| Capital Structure | 56 | 0 |
| Other Social Issues | 28 | 27 |
| Environment or Climate | 23 | 23 |
| Shareholder Rights and Defenses | 16 | 7 |
| Human Rights or Human Capital/workforce | 12 | 12 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Apple Inc. | February 24, 2026 | $161M | 12 | 1 |
| NVIDIA Corporation | June 24, 2026 | $142M | 16 | 4 |
| Microsoft Corporation | December 5, 2025 | $131M | 21 | 6 |
| Meta Platforms, Inc. | May 27, 2026 | $100M | 22 | 9 |
| Amazon.com, Inc. | May 20, 2026 | $77M | 17 | 4 |
| Broadcom Inc. | April 20, 2026 | $64M | 10 | 0 |
| Eli Lilly and Company | May 4, 2026 | $53M | 10 | 2 |
| Visa Inc. | January 27, 2026 | $35M | 18 | 4 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| February 24, 2026 | Apple Inc. | A shareholder proposal entitled "China Entanglement Audit" Shareholder proposal | Against | For |
| June 24, 2026 | NVIDIA Corporation | Approval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposal | For | Against |
| June 24, 2026 | NVIDIA Corporation | Approval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | European Security Program Censorship Risk Audit Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | Report on Risks of Censorship in Generative Artificial Intelligence Shareholder proposal | Against | For |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding report on Al data usage oversight. Shareholder proposal | Against | For |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposal | Against | For |
| May 20, 2026 | Amazon.com, Inc. | SHAREHOLDER PROPOSAL REQUESTING A REPORT ON CHARITABLE PARTNERSHIPS Shareholder proposal | Against | For |
| May 20, 2026 | Amazon.com, Inc. | SHAREHOLDER PROPOSAL REQUESTING ADDITIONAL REPORTING ON IMPACT OF DATA CENTERS ON CLIMATE COMMITMENTS Shareholder proposal | Against | For |
| May 4, 2026 | Eli Lilly and Company | Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposal | For | Against |
| May 4, 2026 | Eli Lilly and Company | Shareholder proposal to prepare an annual lobbying report. Shareholder proposal | Against | For |
| January 27, 2026 | Visa Inc. | Shareholder proposal requesting the Board of Directors to adopt a policy for an independent chair. Shareholder proposal | For | Against |
3,737 ballot items at 340 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, T. Rowe Price Tax-Efficient Equity Fund (PREFX) voted at 340 shareholder meetings of 332 companies, on 3,737 ballot items in all. Where management made a recommendation, the fund followed it on 96.4% of the items and voted against it 132 times. Its most frequent area of disagreement was corporate governance (60 of its votes against management). It voted FOR 18.7% of the 134 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals less often than T. Rowe Price's funds as a whole (86.9% against 93.7%). It voted differently from most T. Rowe Price funds on 239 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of T. Rowe Price’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.